-
1
-
-
33748429057
-
Prevention and early detection of vascular complications of diabetes
-
Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ. 2006;333:475-480.
-
(2006)
BMJ
, vol.333
, pp. 475-480
-
-
Marshall, S.M.1
Flyvbjerg, A.2
-
2
-
-
0026486740
-
Epidemiology of proliferative diabetic retinopathy
-
Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15:1875-1891.
-
(1992)
Diabetes Care
, vol.15
, pp. 1875-1891
-
-
Klein, R.1
Klein, B.E.2
Moss, S.E.3
-
3
-
-
67749088340
-
Microvascular lesions of diabetic retinopathy: Clues towards understanding pathogenesis?
-
(Lond.)
-
Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond.). 2009;23:1496-1508.
-
(2009)
Eye
, vol.23
, pp. 1496-1508
-
-
Curtis, T.M.1
Gardiner, T.A.2
Stitt, A.W.3
-
4
-
-
0348048874
-
Diabetic retinopathy
-
Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
-
(2004)
N Engl J Med
, vol.350
, pp. 48-58
-
-
Frank, R.N.1
-
5
-
-
33750597534
-
Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease
-
Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes.2006;55:2401-2411.
-
(2006)
Diabetes
, vol.55
, pp. 2401-2411
-
-
Antonetti, D.A.1
Barber, A.J.2
Bronson, S.K.3
-
6
-
-
1542636997
-
Oscillatory potential analysis and ERGs of normal and diabetic rats
-
Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Visual Sci. 2004;45: 1002-1008.
-
(2004)
Invest Ophthalmol Visual Sci
, vol.45
, pp. 1002-1008
-
-
Hancock, H.A.1
Kraft, T.W.2
-
7
-
-
0038578086
-
Visual dysfunction, neurodegenerative diseases, and aging
-
Jackson GR, Owsley C. Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin. 2003;21:709-728.
-
(2003)
Neurol Clin
, vol.21
, pp. 709-728
-
-
Jackson, G.R.1
Owsley, C.2
-
8
-
-
4344573553
-
Death of retinal neurons in streptozotocin-induced diabetic mice
-
Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Visual Sci. 2004;45:3330-3336.
-
(2004)
Invest Ophthalmol Visual Sci
, vol.45
, pp. 3330-3336
-
-
Martin, P.M.1
Roon, P.2
van Ells, T.K.3
Ganapathy, V.4
Smith, S.B.5
-
9
-
-
0032529103
-
Neural apoptosis in the retina during experimental and human diabetes: Early onset and effect of insulin
-
Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest.1998;102:783-791.
-
(1998)
J Clin Invest
, vol.102
, pp. 783-791
-
-
Barber, A.J.1
Lieth, E.2
Khin, S.A.3
Antonetti, D.A.4
Buchanan, A.G.5
Gardner, T.W.6
-
10
-
-
84992616516
-
The Diabetes Control and Complications Trial Research Group
-
DCCT. Hypoglycemia in the Diabetes Control and Complications Trial
-
DCCT. Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes. 1993;46:271286.
-
(1993)
Diabetes
, vol.46
, pp. 271-286
-
-
-
11
-
-
0032511566
-
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
-
(UKPDS) UPDS
-
(UKPDS) UPDS. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
12
-
-
54949157448
-
Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives
-
Madsen-Bouterse SA, Kowluru RA. Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Rev Endocr Metab Disord. 2008;9:315-327.
-
(2008)
Rev Endocr Metab Disord
, vol.9
, pp. 315-327
-
-
Madsen-Bouterse, S.A.1
Kowluru, R.A.2
-
13
-
-
0035856980
-
Biochemistry and molecular cell biology of diabetic complications
-
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-820.
-
(2001)
Nature
, vol.414
, pp. 813-820
-
-
Brownlee, M.1
-
14
-
-
33947631272
-
The potential role of thiamine (vitamin B1) in diabetic complications
-
Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev. 2005;1:287-298.
-
(2005)
Curr Diabetes Rev
, vol.1
, pp. 287-298
-
-
Thornalley, P.J.1
-
15
-
-
33646938091
-
Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose
-
Berrone E, Beltramo E, Solimine C, Ape AU, Porta M. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem. 2006;281:9307-9313.
-
(2006)
J Biol Chem
, vol.281
, pp. 9307-9313
-
-
Berrone, E.1
Beltramo, E.2
Solimine, C.3
Ape, A.U.4
Porta, M.5
-
16
-
-
0344837347
-
Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy
-
Hammes HP, Du X, Edelstein D, et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003;9:294-299.
-
(2003)
Nat Med
, vol.9
, pp. 294-299
-
-
Hammes, H.P.1
Du, X.2
Edelstein, D.3
-
17
-
-
23744467295
-
Glycation products as markers and predictors of the progression of diabetic complications
-
Monnier VM, Sell DR, Genuth S. Glycation products as markers and predictors of the progression of diabetic complications. Ann N Y Acad Sci. 2005;1043:567-581.
-
(2005)
Ann N Y Acad Sci
, vol.1043
, pp. 567-581
-
-
Monnier, V.M.1
Sell, D.R.2
Genuth, S.3
-
18
-
-
33746920337
-
Advanced glycation end products: Sparking the development of diabetic vascular injury
-
Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114:597-605.
-
(2006)
Circulation
, vol.114
, pp. 597-605
-
-
Goldin, A.1
Beckman, J.A.2
Schmidt, A.M.3
Creager, M.A.4
-
19
-
-
0346731073
-
Maillard reaction products in tissue proteins: New products and new perspectives
-
Thorpe SR, Baynes JW. Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids.2003;25:275-281.
-
(2003)
Amino Acids
, vol.25
, pp. 275-281
-
-
Thorpe, S.R.1
Baynes, J.W.2
-
20
-
-
0028951937
-
Metabolism of fructose-3- phosphate in the diabetic rat lens
-
Lal S, Szwergold BS, Taylor AH, et al. Metabolism of fructose-3- phosphate in the diabetic rat lens. Arch Biochem Biophys. 1995; 318:191-199.
-
(1995)
Arch Biochem Biophys
, vol.318
, pp. 191-199
-
-
Lal, S.1
Szwergold, B.S.2
Taylor, A.H.3
-
21
-
-
0035834748
-
Amides are novel protein modifications formed by physiological sugars
-
Glomb MA, Pfahler C. Amides are novel protein modifications formed by physiological sugars. J Biol Chem. 2001;276:41638-41647.
-
(2001)
J Biol Chem
, vol.276
, pp. 41638-41647
-
-
Glomb, M.A.1
Pfahler, C.2
-
22
-
-
0033571012
-
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose
-
Thornalley PJ, Langborg A, Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J. 1999;344:109-116.
-
(1999)
Biochem J
, vol.344
, pp. 109-116
-
-
Thornalley, P.J.1
Langborg, A.2
Minhas, H.S.3
-
23
-
-
0037302018
-
Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes
-
Kilhovd BK, Giardino I, Torjesen PA, et al. Increased serum levels of the specific AGE-compound methylglyoxal-derived hydroimidazolone in patients with type 2 diabetes. Metabolism. 2003;52: 163-167.
-
(2003)
Metabolism
, vol.52
, pp. 163-167
-
-
Kilhovd, B.K.1
Giardino, I.2
Torjesen, P.A.3
-
25
-
-
0037406409
-
AGEs in foods: Do they play a role in uremia?
-
Henle T. AGEs in foods: do they play a role in uremia? Kidney Int Suppl. 2003;S145-S147.
-
(2003)
Kidney Int Suppl
-
-
Henle, T.1
-
26
-
-
0030992848
-
Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy
-
Koschinsky T, He CJ, Mitsuhashi T, et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A. 1997;94:6474-6479.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 6474-6479
-
-
Koschinsky, T.1
He, C.J.2
Mitsuhashi, T.3
-
27
-
-
23744440311
-
Diet-derived advanced glycation end products are major contrib-utors to the body's AGE pool and induce inflammation in healthy subjects
-
Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. Diet-derived advanced glycation end products are major contrib-utors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci. 2005;1043:461-466.
-
(2005)
Ann N Y Acad Sci
, vol.1043
, pp. 461-466
-
-
Uribarri, J.1
Cai, W.2
Sandu, O.3
Peppa, M.4
Goldberg, T.5
Vlassara, H.6
-
28
-
-
0037180567
-
Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy
-
Vlassara H, Cai W, Crandall J, et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A. 2002;99:15596-15601.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 15596-15601
-
-
Vlassara, H.1
Cai, W.2
Crandall, J.3
-
29
-
-
23744443807
-
Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease
-
Kuhla B, Luth HJ, Haferburg D, Boeck K, Arendt T, Munch G. Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci. 2005;1043:211-216.
-
(2005)
Ann N Y Acad Sci
, vol.1043
, pp. 211-216
-
-
Kuhla, B.1
Luth, H.J.2
Haferburg, D.3
Boeck, K.4
Arendt, T.5
Munch, G.6
-
30
-
-
0032032578
-
Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia- induced increases in macromolecular endocytosis
-
Shinohara M, Thornalley PJ, Giardino I, et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia- induced increases in macromolecular endocytosis. J Clin Invest. 1998;101:1142-1147.
-
(1998)
J Clin Invest
, vol.101
, pp. 1142-1147
-
-
Shinohara, M.1
Thornalley, P.J.2
Giardino, I.3
-
31
-
-
35649026775
-
High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A
-
Yao D, Taguchi T, Matsumura T, et al. High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem.2007;282:31038-31045.
-
(2007)
J Biol Chem
, vol.282
, pp. 31038-31045
-
-
Yao, D.1
Taguchi, T.2
Matsumura, T.3
-
32
-
-
33744959529
-
Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions
-
Miller AG, Smith DG, Bhat M, Nagaraj RH. Glyoxalase I is critical for human retinal capillary pericyte survival under hyperglycemic conditions. J Biol Chem. 2006;281:11864-11871.
-
(2006)
J Biol Chem
, vol.281
, pp. 11864-11871
-
-
Miller, A.G.1
Smith, D.G.2
Bhat, M.3
Nagaraj, R.H.4
-
33
-
-
40549129694
-
Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans
-
Morcos M, Du X, Pfisterer F, et al. Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging cell. 2008;7:260-269.
-
(2008)
Aging Cell
, vol.7
, pp. 260-269
-
-
Morcos, M.1
Du, X.2
Pfisterer, F.3
-
34
-
-
70350365865
-
C. elegans as model for the study of high glucose-mediated life span reduction
-
Schlotterer A, Kukudov G, Bozorgmehr F, et al. C. elegans as model for the study of high glucose-mediated life span reduction. Diabetes. 2009;58:2450-2456.
-
(2009)
Diabetes
, vol.58
, pp. 2450-2456
-
-
Schlotterer, A.1
Kukudov, G.2
Bozorgmehr, F.3
-
35
-
-
28044450610
-
A lethal tetrad in diabetes: Hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction
-
Yu Y, Lyons TJ. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction. Am J Med Sci. 2005;330:227-232.
-
(2005)
Am J Med Sci
, vol.330
, pp. 227-232
-
-
Yu, Y.1
Lyons, T.J.2
-
36
-
-
0034647739
-
Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions: Mechanism of action of pyridoxamine
-
Onorato JM, Jenkins AJ, Thorpe SR, Baynes JW. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions: mechanism of action of pyridoxamine. J Biol Chem. 2000;275:21177-21184.
-
(2000)
J Biol Chem
, vol.275
, pp. 21177-21184
-
-
Onorato, J.M.1
Jenkins, A.J.2
Thorpe, S.R.3
Baynes, J.W.4
-
37
-
-
0032538529
-
Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids
-
Miyata T, Inagi R, Asahi K, et al. Generation of protein carbonyls by glycoxidation and lipoxidation reactions with autoxidation products of ascorbic acid and polyunsaturated fatty acids. FEBS Lett. 1998;437:24-28.
-
(1998)
FEBS Lett
, vol.437
, pp. 24-28
-
-
Miyata, T.1
Inagi, R.2
Asahi, K.3
-
38
-
-
49249091368
-
Evaluation of N (epsilon)-(3- formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy
-
Zhang X, Lai Y, McCance DR, et al. Evaluation of N (epsilon)-(3- formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy. Diabetologia. 2008;51:1723-1730.
-
(2008)
Diabetologia
, vol.51
, pp. 1723-1730
-
-
Zhang, X.1
Lai, Y.2
McCance, D.R.3
-
39
-
-
0032143589
-
Increased serum levels of advanced glycation end-products and diabetic complications
-
Ono Y, Aoki S, Ohnishi K, Yasuda T, Kawano K, Tsukada Y. Increased serum levels of advanced glycation end-products and diabetic complications. Diabetes Res Clin Pract. 1998;41:131-137.
-
(1998)
Diabetes Res Clin Pract
, vol.41
, pp. 131-137
-
-
Ono, Y.1
Aoki, S.2
Ohnishi, K.3
Yasuda, T.4
Kawano, K.5
Tsukada, Y.6
-
40
-
-
0031752572
-
Plasma levels of pentosidine in diabetic patients: An advanced glycation end product
-
Sugiyama S, Miyata T, Ueda Y, et al. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol. 1998;9:1681-1688.
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 1681-1688
-
-
Sugiyama, S.1
Miyata, T.2
Ueda, Y.3
-
41
-
-
7144227270
-
Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy
-
Yamaguchi M, Nakamura N, Nakano K, et al. Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy. Diabet Med. 1998;15:458-462.
-
(1998)
Diabet Med
, vol.15
, pp. 458-462
-
-
Yamaguchi, M.1
Nakamura, N.2
Nakano, K.3
-
42
-
-
30744468605
-
Increased serum levels of the specific advanced glycation end product methylglyoxal- derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus
-
Fosmark DS, Torjesen PA, Kilhovd BK, et al. Increased serum levels of the specific advanced glycation end product methylglyoxal- derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Metabol Clin Exp.2006;55:232-236.
-
(2006)
Metabol Clin Exp
, vol.55
, pp. 232-236
-
-
Fosmark, D.S.1
Torjesen, P.A.2
Kilhovd, B.K.3
-
43
-
-
0034741275
-
N(epsilon)-(carboxymethyl) lysine levels in patients with type 2 diabetes: Role of renal function
-
Wagner Z, Wittmann I, Mazak I, et al. N(epsilon)-(carboxymethyl) lysine levels in patients with type 2 diabetes: role of renal function. Am J Kidney Dis. 2001;38:785-791.
-
(2001)
Am J Kidney Dis
, vol.38
, pp. 785-791
-
-
Wagner, Z.1
Wittmann, I.2
Mazak, I.3
-
44
-
-
0026675759
-
Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM
-
Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes. 1992;41:1286-1292.
-
(1992)
Diabetes
, vol.41
, pp. 1286-1292
-
-
Sell, D.R.1
Lapolla, A.2
Odetti, P.3
Fogarty, J.4
Monnier, V.M.5
-
45
-
-
33644698951
-
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes
-
Genuth S, Sun W, Cleary P, et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes. 2005;54:3103-3111.
-
(2005)
Diabetes
, vol.54
, pp. 3103-3111
-
-
Genuth, S.1
Sun, W.2
Cleary, P.3
-
46
-
-
0037093012
-
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
-
Team W. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. Jama. 2002;287:2563-2569.
-
(2002)
Jama
, vol.287
, pp. 2563-2569
-
-
Team, W.1
-
47
-
-
0034985014
-
Advanced glycation: An important pathological event in diabetic and age related ocular disease
-
Stitt AW. Advanced glycation: an important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001; 85:746-753.
-
(2001)
Br J Ophthalmol
, vol.85
, pp. 746-753
-
-
Stitt, A.W.1
-
48
-
-
0031736635
-
Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy
-
Stitt AW, Moore JE, Sharkey JA, et al. Advanced glycation end products in vitreous: structural and functional implications for diabetic vitreopathy. Invest Ophthalmol Visual Sci. 1998;39: 2517-2523.
-
(1998)
Invest Ophthalmol Visual Sci
, vol.39
, pp. 2517-2523
-
-
Stitt, A.W.1
Moore, J.E.2
Sharkey, J.A.3
-
49
-
-
34548203887
-
Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: A case-control study
-
Fosmark DS, Bragadottir R, Stene-Johansen I, et al. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study. Acta Ophthalmol Scand. 2007;85:618-622.
-
(2007)
Acta Ophthalmol Scand
, vol.85
, pp. 618-622
-
-
Fosmark, D.S.1
Bragadottir, R.2
Stene-Johansen, I.3
-
50
-
-
0141961133
-
Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes
-
Gardiner TA, Anderson HR, Stitt AW. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol. 2003; 201:328-333.
-
(2003)
J Pathol
, vol.201
, pp. 328-333
-
-
Gardiner, T.A.1
Anderson, H.R.2
Stitt, A.W.3
-
51
-
-
0033028542
-
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
-
Hammes HP, Alt A, Niwa T, et al. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy. Diabetologia. 1999;42:728-736.
-
(1999)
Diabetologia
, vol.42
, pp. 728-736
-
-
Hammes, H.P.1
Alt, A.2
Niwa, T.3
-
52
-
-
0030805762
-
The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas
-
Murata T, Nagai R, Ishibashi T, Inomuta H, Ikeda K, Horiuchi S. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia. 1997;40:764-769.
-
(1997)
Diabetologia
, vol.40
, pp. 764-769
-
-
Murata, T.1
Nagai, R.2
Ishibashi, T.3
Inomuta, H.4
Ikeda, K.5
Horiuchi, S.6
-
53
-
-
0033512695
-
Amadori albumin in type 1 diabetic patients: Correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries
-
Schalkwijk CG, Ligtvoet N, Twaalfhoven H, et al. Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries. Diabetes. 1999;48:2446-2453.
-
(1999)
Diabetes
, vol.48
, pp. 2446-2453
-
-
Schalkwijk, C.G.1
Ligtvoet, N.2
Twaalfhoven, H.3
-
54
-
-
0031019612
-
Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats
-
Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol. 1997;150:523-531.
-
(1997)
Am J Pathol
, vol.150
, pp. 523-531
-
-
Stitt, A.W.1
Li, Y.M.2
Gardiner, T.A.3
Bucala, R.4
Archer, D.B.5
Vlassara, H.6
-
55
-
-
0028107538
-
Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat
-
Hammes HP, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia.1994;37:32-35.
-
(1994)
Diabetologia
, vol.37
, pp. 32-35
-
-
Hammes, H.P.1
Brownlee, M.2
Edelstein, D.3
Saleck, M.4
Martin, S.5
Federlin, K.6
-
56
-
-
0348049805
-
Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats
-
Karachalias N, Babaei-Jadidi R, Ahmed N, Thornalley PJ. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats. Biochem Soc Trans. 2003;31:1423-1425.
-
(2003)
Biochem Soc Trans
, vol.31
, pp. 1423-1425
-
-
Karachalias, N.1
Babaei-Jadidi, R.2
Ahmed, N.3
Thornalley, P.J.4
-
57
-
-
0036723821
-
The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes
-
Stitt A, Gardiner TA, Alderson NL, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes. 2002;51:2826-2832.
-
(2002)
Diabetes
, vol.51
, pp. 2826-2832
-
-
Stitt, A.1
Gardiner, T.A.2
Alderson, N.L.3
-
58
-
-
0036175576
-
Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes
-
Agardh E, Bruun A, Agardh CD. Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZ-induced diabetes. Curr Eye Res. 2001;23:276-284.
-
(2001)
Curr Eye Res
, vol.23
, pp. 276-284
-
-
Agardh, E.1
Bruun, A.2
Agardh, C.D.3
-
59
-
-
34248215127
-
Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration
-
de Gooyer TE, Stevenson KA, Humphries P, Simpson DA, Gardiner TA, Stitt AW. Retinopathy is reduced during experimental diabetes in a mouse model of outer retinal degeneration. Invest Ophthalmol Vis Sci. 2006;47:5561-5568.
-
(2006)
Invest Ophthalmol Vis Sci
, vol.47
, pp. 5561-5568
-
-
de Gooyer, T.E.1
Stevenson, K.A.2
Humphries, P.3
Simpson, D.A.4
Gardiner, T.A.5
Stitt, A.W.6
-
60
-
-
0031594369
-
Müller cell changes in human diabetic retinopathy
-
Mizutani M, Gerhardinger C, Lorenzi M. Müller cell changes in human diabetic retinopathy. Diabetes. 1998;47:445-449.
-
(1998)
Diabetes
, vol.47
, pp. 445-449
-
-
Mizutani, M.1
Gerhardinger, C.2
Lorenzi, M.3
-
61
-
-
0344012015
-
Hyperglycemia increases mitochondrial superoxide in retina and retinal cells
-
Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med.2003;35:1491-1499.
-
(2003)
Free Radic Biol Med
, vol.35
, pp. 1491-1499
-
-
Du, Y.1
Miller, C.M.2
Kern, T.S.3
-
62
-
-
0142061182
-
NADPH diaphorase activity in the rat retina during the early stages of experimental diabetes
-
Li Q, Zemel E, Miller B, Perlman I. NADPH diaphorase activity in the rat retina during the early stages of experimental diabetes. Graefes Arch Clin Exp Ophthalmol. 2003;241:747-756.
-
(2003)
Graefes Arch Clin Exp Ophthalmol
, vol.241
, pp. 747-756
-
-
Li, Q.1
Zemel, E.2
Miller, B.3
Perlman, I.4
-
63
-
-
0036981941
-
Diabetes-induced dysfunction of retinal Müller cells
-
Puro DG. Diabetes-induced dysfunction of retinal Müller cells. Trans Am Ophthalmol Soc. 2002;100:339-352.
-
(2002)
Trans Am Ophthalmol Soc
, vol.100
, pp. 339-352
-
-
Puro, D.G.1
-
64
-
-
0031919598
-
Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy
-
Penn State Retina Research Group
-
Lieth E, Barber AJ, Xu B, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes. 1998;47: 815-820.
-
(1998)
Diabetes
, vol.47
, pp. 815-820
-
-
Lieth, E.1
Barber, A.J.2
Xu, B.3
-
65
-
-
2442582748
-
Cultured retinal neuronal cells and Müller cells both show net production of lactate
-
Winkler BS, Starnes CA, Sauer MW, Firouzgan Z, Chen SC. Cultured retinal neuronal cells and Müller cells both show net production of lactate. Neurochem Int. 2004;45:311-320.
-
(2004)
Neurochem Int
, vol.45
, pp. 311-320
-
-
Winkler, B.S.1
Starnes, C.A.2
Sauer, M.W.3
Firouzgan, Z.4
Chen, S.C.5
-
66
-
-
0031762824
-
Lipid peroxidation products and antioxidants in human disease
-
Romero FJ, Bosch-Morell F, Romero MJ, et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect. 1998;106(suppl 5):1229-1234.
-
(1998)
Environ Health Perspect
, vol.106
, Issue.SUPPL. 5
, pp. 1229-1234
-
-
Romero, F.J.1
Bosch-Morell, F.2
Romero, M.J.3
-
67
-
-
0031737982
-
Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress
-
Loske C, Neumann A, Cunningham AM, et al. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J Neural Transm. 1998;105:1005-1015.
-
(1998)
J Neural Transm
, vol.105
, pp. 1005-1015
-
-
Loske, C.1
Neumann, A.2
Cunningham, A.M.3
-
68
-
-
0029882361
-
Involvement of glycation and oxidative stress in diabetic macroangiopathy
-
Taniguchi N, Kaneto H, Asahi M, et al. Involvement of glycation and oxidative stress in diabetic macroangiopathy. Diabetes. 1996; 45(suppl 3):S81-S83.
-
(1996)
Diabetes
, vol.45
, Issue.SUPPL. 3
-
-
Taniguchi, N.1
Kaneto, H.2
Asahi, M.3
-
69
-
-
77649189371
-
Molecular pathology of oxidative stress in diabetic angiopathy: Role of mitochondrial and cellular pathways
-
Mokini Z, Marcovecchio ML, Chiarelli F. Molecular pathology of oxidative stress in diabetic angiopathy: role of mitochondrial and cellular pathways. Diabetes Res Clin Pract. 2010;87:313-321.
-
(2010)
Diabetes Res Clin Pract
, vol.87
, pp. 313-321
-
-
Mokini, Z.1
Marcovecchio, M.L.2
Chiarelli, F.3
-
70
-
-
63849118178
-
Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy
-
Zheng L, Kern TS. Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy. Front Biosci. 2009;14:3974-3987.
-
(2009)
Front Biosci
, vol.14
, pp. 3974-3987
-
-
Zheng, L.1
Kern, T.S.2
-
71
-
-
28844466951
-
Diabetic retinopathy: Mitochondrial dysfunction and retinal capillary cell death
-
Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antioxid Redox Signal. 2005;7: 1581-1587.
-
(2005)
Antioxid Redox Signal
, vol.7
, pp. 1581-1587
-
-
Kowluru, R.A.1
-
72
-
-
0142180047
-
Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants
-
Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res. 2003;37:1169-1180.
-
(2003)
Free Radic Res
, vol.37
, pp. 1169-1180
-
-
Kowluru, R.A.1
Koppolu, P.2
Chakrabarti, S.3
Chen, S.4
-
74
-
-
9444224415
-
Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats
-
Kowluru RA, Odenbach S. Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes. 2004;53:3233-3238.
-
(2004)
Diabetes
, vol.53
, pp. 3233-3238
-
-
Kowluru, R.A.1
Odenbach, S.2
-
75
-
-
33749070956
-
Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress
-
Kowluru RA, Kowluru V, Xiong Y, Ho YS. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med.2006;41:1191-1196.
-
(2006)
Free Radic Biol Med
, vol.41
, pp. 1191-1196
-
-
Kowluru, R.A.1
Kowluru, V.2
Xiong, Y.3
Ho, Y.S.4
-
76
-
-
33847261189
-
Arteriolar involvement in the microvascular lesions of diabetic retinopathy: Implications for pathogenesis
-
Gardiner TA, Archer DB, Curtis TM, Stitt AW. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Microcirculation. 2007;14:25-38.
-
(2007)
Microcirculation
, vol.14
, pp. 25-38
-
-
Gardiner, T.A.1
Archer, D.B.2
Curtis, T.M.3
Stitt, A.W.4
-
77
-
-
0033071239
-
Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas
-
Li W, Yanoff M, Jian B, He Z. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cell Mol Biol (Noisy-le-grand). 1999;45:59-66.
-
(1999)
Cell Mol Biol (Noisy-le-grand)
, vol.45
, pp. 59-66
-
-
Li, W.1
Yanoff, M.2
Jian, B.3
He, Z.4
-
78
-
-
33746019252
-
Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes
-
Chen BH, Jiang DY, Tang LS. Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes. Life Sci. 2006;79:1040-1048.
-
(2006)
Life Sci
, vol.79
, pp. 1040-1048
-
-
Chen, B.H.1
Jiang, D.Y.2
Tang, L.S.3
-
79
-
-
0033542085
-
Advanced glycation endproducts accelerate calcification in microvascular pericytes
-
Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H. Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun. 1999; 258:353-357.
-
(1999)
Biochem Biophys Res Commun
, vol.258
, pp. 353-357
-
-
Yamagishi, S.1
Fujimori, H.2
Yonekura, H.3
Tanaka, N.4
Yamamoto, H.5
-
80
-
-
23844515492
-
2+]i signalling and contraction in retinal microvascular pericytes
-
2+]i signalling and contraction in retinal microvascular pericytes. Mol Vis. 2004;10:996-1004.
-
(2004)
Mol Vis
, vol.10
, pp. 996-1004
-
-
Hughes, S.J.1
Wall, N.2
Scholfield, C.N.3
-
81
-
-
3042531282
-
Effect of dicarbonyl modification of fibronectin on retinal capillary pericytes
-
Liu B, Bhat M, Padival AK, Smith DG, Nagaraj RH. Effect of dicarbonyl modification of fibronectin on retinal capillary pericytes. Invest Ophthalmol Visual Sci. 2004;45:1983-1995.
-
(2004)
Invest Ophthalmol Visual Sci
, vol.45
, pp. 1983-1995
-
-
Liu, B.1
Bhat, M.2
Padival, A.K.3
Smith, D.G.4
Nagaraj, R.H.5
-
82
-
-
1242318593
-
Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: Inhibitory effect of gliclazide
-
Mamputu JC, Renier G. Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide. Diabetes Obes Metab.2004;6:95-103.
-
(2004)
Diabetes Obes Metab
, vol.6
, pp. 95-103
-
-
Mamputu, J.C.1
Renier, G.2
-
83
-
-
0031019299
-
Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: Relevance to diabetic retinopathy
-
Chibber R, Molinatti PA, Rosatto N, Lambourne B, Kohner EM. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy. Diabetologia. 1997;40:156-164.
-
(1997)
Diabetologia
, vol.40
, pp. 156-164
-
-
Chibber, R.1
Molinatti, P.A.2
Rosatto, N.3
Lambourne, B.4
Kohner, E.M.5
-
84
-
-
14644435056
-
Impaired retinal angiogenesis in diabetes: Role of advanced glycation end products and galectin-3
-
Stitt AW, McGoldrick C, Rice-McCaldin A, et al. Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes. 2005;54:785-794.
-
(2005)
Diabetes
, vol.54
, pp. 785-794
-
-
Stitt, A.W.1
McGoldrick, C.2
Rice-McCaldin, A.3
-
85
-
-
0036247573
-
High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells
-
Padayatti PS, Jiang C, Glomb MA, Uchida K, Nagaraj RH. High concentrations of glucose induce synthesis of argpyrimidine in retinal endothelial cells. Curr Eye Res. 2001;23:106-115.
-
(2001)
Curr Eye Res
, vol.23
, pp. 106-115
-
-
Padayatti, P.S.1
Jiang, C.2
Glomb, M.A.3
Uchida, K.4
Nagaraj, R.H.5
-
86
-
-
0141541794
-
The role of advanced glycation end products in retinal microvascular leukostasis
-
Moore TC, Moore JE, Kaji Y, et al. The role of advanced glycation end products in retinal microvascular leukostasis. Invest Ophthalmol Visual Sci. 2003;44:4457-4464.
-
(2003)
Invest Ophthalmol Visual Sci
, vol.44
, pp. 4457-4464
-
-
Moore, T.C.1
Moore, J.E.2
Kaji, Y.3
-
87
-
-
34247354628
-
Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes
-
Canning P, Glenn JV, Hsu DK, Liu FT, Gardiner TA, Stitt AW. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes. Exp Diabetes Res. 2007;2007:51837.
-
(2007)
Exp Diabetes Res
, vol.2007
, pp. 51837
-
-
Canning, P.1
Glenn, J.V.2
Hsu, D.K.3
Liu, F.T.4
Gardiner, T.A.5
Stitt, A.W.6
-
88
-
-
0037263160
-
Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: A factor in diabetic retinopathy
-
Xu X, Li Z, Luo D, et al. Exogenous advanced glycosylation end products induce diabetes-like vascular dysfunction in normal rats: a factor in diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol.2003;241:56-62.
-
(2003)
Graefes Arch Clin Exp Ophthalmol
, vol.241
, pp. 56-62
-
-
Xu, X.1
Li, Z.2
Luo, D.3
-
89
-
-
0022644227
-
Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking
-
Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking. Science. 1986;232:1629-1632.
-
(1986)
Science
, vol.232
, pp. 1629-1632
-
-
Brownlee, M.1
Vlassara, H.2
Kooney, A.3
Ulrich, P.4
Cerami, A.5
-
90
-
-
0142121508
-
Therapeutic potential of breakers of advanced glycation end product-protein crosslinks
-
Vasan S, Foiles P, Founds H. Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. Arch Biochem Biophys. 2003;419:89-96.
-
(2003)
Arch Biochem Biophys
, vol.419
, pp. 89-96
-
-
Vasan, S.1
Foiles, P.2
Founds, H.3
-
91
-
-
0026323337
-
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy
-
Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci U S A. 1991;88:11555-11558.
-
(1991)
Proc Natl Acad Sci U S A
, vol.88
, pp. 11555-11558
-
-
Hammes, H.P.1
Martin, S.2
Federlin, K.3
Geisen, K.4
Brownlee, M.5
-
92
-
-
0035409354
-
Pharmacological inhibition of diabetic retinopathy: Aminoguanidine and aspirin
-
Kern TS, Engerman RL. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes. 2001;50: 1636-1642.
-
(2001)
Diabetes
, vol.50
, pp. 1636-1642
-
-
Kern, T.S.1
Engerman, R.L.2
-
93
-
-
0033733494
-
Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats
-
Agardh E, Hultberg B, Agardh C. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats. Curr Eye Res. 2000;21:543-549.
-
(2000)
Curr Eye Res
, vol.21
, pp. 543-549
-
-
Agardh, E.1
Hultberg, B.2
Agardh, C.3
-
94
-
-
10744223527
-
Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy
-
Bolton WK, Cattran DC, Williams ME, et al. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy. Am J Nephrol. 2004;24:32-40.
-
(2004)
Am J Nephrol
, vol.24
, pp. 32-40
-
-
Bolton, W.K.1
Cattran, D.C.2
Williams, M.E.3
-
95
-
-
50049083519
-
Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats
-
Ren XY, Li YN, Qi JS, Niu T. Peroxynitrite-induced protein nitration contributes to liver mitochondrial damage in diabetic rats. J Diabetes Complications. 2008;22:357-364.
-
(2008)
J Diabetes Complications
, vol.22
, pp. 357-364
-
-
Ren, X.Y.1
Li, Y.N.2
Qi, J.S.3
Niu, T.4
-
96
-
-
0033551042
-
Amadorins: Novel post- Amadori inhibitors of advanced glycation reactions
-
Khalifah RG, Baynes JW, Hudson BG. Amadorins: novel post- Amadori inhibitors of advanced glycation reactions. Biochem Biophys Res Commun. 1999;257:251-258.
-
(1999)
Biochem Biophys Res Commun
, vol.257
, pp. 251-258
-
-
Khalifah, R.G.1
Baynes, J.W.2
Hudson, B.G.3
-
97
-
-
0036479252
-
A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation
-
Voziyan PA, Metz TO, Baynes JW, Hudson BG. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem. 2002;277:3397-3403.
-
(2002)
J Biol Chem
, vol.277
, pp. 3397-3403
-
-
Voziyan, P.A.1
Metz, T.O.2
Baynes, J.W.3
Hudson, B.G.4
-
98
-
-
34548299920
-
Novel inhibitors of glycation and AGE formation
-
Rahbar S. Novel inhibitors of glycation and AGE formation. Cell Biochem Biophys. 2007;48:147-157.
-
(2007)
Cell Biochem Biophys
, vol.48
, pp. 147-157
-
-
Rahbar, S.1
-
99
-
-
41849131467
-
A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats
-
Bhatwadekar A, Glenn JV, Figarola JL, et al. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats. Br J Ophthalmol. 2008;92:545-547.
-
(2008)
Br J Ophthalmol
, vol.92
, pp. 545-547
-
-
Bhatwadekar, A.1
Glenn, J.V.2
Figarola, J.L.3
-
100
-
-
67650227476
-
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy
-
Gerhardinger C, Dagher Z, Sebastiani P, Seek Park Y, Lorenzi M. The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy. Diabetes.2009;58:1659-1667.
-
(2009)
Diabetes
, vol.58
, pp. 1659-1667
-
-
Gerhardinger, C.1
Dagher, Z.2
Sebastiani, P.3
Seek, P.Y.4
Lorenzi, M.5
-
101
-
-
69349088835
-
Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response
-
Brucklacher RM, Patel KM, VanGuilder HD, et al. Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics.2008;1:26.
-
(2008)
BMC Med Genomics
, vol.1
, pp. 26
-
-
Brucklacher, R.M.1
Patel, K.M.2
van Guilder, H.D.3
-
102
-
-
33847048626
-
Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia
-
Vincent JA, Mohr S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes. 2007;56:224-230.
-
(2007)
Diabetes
, vol.56
, pp. 224-230
-
-
Vincent, J.A.1
Mohr, S.2
-
103
-
-
70749133081
-
Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: Novel mechanism for metabolic memory
-
Chan PS, Kanwar M, Kowluru RA. Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory. J Diabetes Complications. 2010;24:55-63.
-
(2010)
J Diabetes Complications
, vol.24
, pp. 55-63
-
-
Chan, P.S.1
Kanwar, M.2
Kowluru, R.A.3
-
104
-
-
7044228789
-
A central role for inflammation in the pathogenesis of diabetic retinopathy
-
Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004; 18:1450-1452.
-
(2004)
FASEB J
, vol.18
, pp. 1450-1452
-
-
Joussen, A.M.1
Poulaki, V.2
Le, M.L.3
-
105
-
-
3543043820
-
Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina
-
Kuiper EJ, Witmer AN, Klaassen I, Oliver N, Goldschmeding R, Schlingemann RO. Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina. Br J Ophthalmol. 2004;88:1082-1087.
-
(2004)
Br J Ophthalmol
, vol.88
, pp. 1082-1087
-
-
Kuiper, E.J.1
Witmer, A.N.2
Klaassen, I.3
Oliver, N.4
Goldschmeding, R.5
Schlingemann, R.O.6
-
106
-
-
39049127031
-
Microglial activation in human diabetic retinopathy
-
Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch Ophthalmol. 2008;126:227-232.
-
(2008)
Arch Ophthalmol
, vol.126
, pp. 227-232
-
-
Zeng, H.Y.1
Green, W.R.2
Tso, M.O.3
-
108
-
-
0033921527
-
Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats
-
Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci.2000;17:463-471.
-
(2000)
Vis Neurosci
, vol.17
, pp. 463-471
-
-
Zeng, X.X.1
Ng, Y.K.2
Ling, E.A.3
-
109
-
-
0033615356
-
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression
-
Kislinger T, Fu C, Huber B, et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem. 1999;274:31740-31749.
-
(1999)
J Biol Chem
, vol.274
, pp. 31740-31749
-
-
Kislinger, T.1
Fu, C.2
Huber, B.3
-
110
-
-
2942756123
-
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
-
Liliensiek B, Weigand MA, Bierhaus A, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113:1641-1650.
-
(2004)
J Clin Invest
, vol.113
, pp. 1641-1650
-
-
Liliensiek, B.1
Weigand, M.A.2
Bierhaus, A.3
-
111
-
-
0033603241
-
RAGE mediates a novel proinflammatory axis: A central cell surface receptor for S100/ calgranulin polypeptides
-
Hofmann MA, Drury S, Fu C, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/ calgranulin polypeptides. Cell. 1999;97:889-901.
-
(1999)
Cell
, vol.97
, pp. 889-901
-
-
Hofmann, M.A.1
Drury, S.2
Fu, C.3
-
112
-
-
0013615899
-
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease
-
Yan SD, Chen X, Fu J, et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 1996;382:685-691.
-
(1996)
Nature
, vol.382
, pp. 685-691
-
-
Yan, S.D.1
Chen, X.2
Fu, J.3
-
113
-
-
0027718105
-
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues
-
Brett J, Schmidt AM, Yan SD, et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol. 1993;143:1699-1712.
-
(1993)
Am J Pathol
, vol.143
, pp. 1699-1712
-
-
Brett, J.1
Schmidt, A.M.2
Yan, S.D.3
-
114
-
-
10744229528
-
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment
-
Chavakis T, Bierhaus A, Al-Fakhri N, et al. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med.2003;198:1507-1515.
-
(2003)
J Exp Med
, vol.198
, pp. 1507-1515
-
-
Chavakis, T.1
Bierhaus, A.2
Al-Fakhri, N.3
-
115
-
-
0033779614
-
RAGE: A new target for the prevention and treatment of the vascular and inflammatory complications of diabetes
-
Schmidt AM, Stern DM. RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol Metab. 2000;11:368-375.
-
(2000)
Trends Endocrinol Metab
, vol.11
, pp. 368-375
-
-
Schmidt, A.M.1
Stern, D.M.2
-
116
-
-
27744453362
-
Understanding RAGE, the receptor for advanced glycation end products
-
Bierhaus A, Humpert PM, Morcos M, et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med.2005;83:876-886.
-
(2005)
J Mol Med
, vol.83
, pp. 876-886
-
-
Bierhaus, A.1
Humpert, P.M.2
Morcos, M.3
-
117
-
-
77954891042
-
Homodimerisation is essential for the receptor for advanced glycation end-products (RAGE)-mediated signal transduction
-
Zong H, Madden A, Ward M, Mooney MH, Elliott CT, Stitt AW. Homodimerisation is essential for the receptor for advanced glycation end-products (RAGE)-mediated signal transduction. J Biol Chem. 2010;23:23137-23146.
-
(2010)
J Biol Chem
, vol.23
, pp. 23137-23146
-
-
Zong, H.1
Madden, A.2
Ward, M.3
Mooney, M.H.4
Elliott, C.T.5
Stitt, A.W.6
-
118
-
-
57749122052
-
Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42
-
Hudson BI, Kalea AZ, Del Mar Arriero M, et al. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem. 2008;283:34457-34468.
-
(2008)
J Biol Chem
, vol.283
, pp. 34457-34468
-
-
Hudson, B.I.1
Kalea, A.Z.2
del Mar Arriero, M.3
-
119
-
-
28344438623
-
S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells
-
Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res. 2006;312:184-197.
-
(2006)
Exp Cell Res
, vol.312
, pp. 184-197
-
-
Hermani, A.1
de Servi, B.2
Medunjanin, S.3
Tessier, P.A.4
Mayer, D.5
-
120
-
-
70149100697
-
RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line
-
Chuong C, Katz J, Pauley KM, Bulosan M, Cha S. RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line. J Cell Physiol. 2009;221: 430-434.
-
(2009)
J Cell Physiol
, vol.221
, pp. 430-434
-
-
Chuong, C.1
Katz, J.2
Pauley, K.M.3
Bulosan, M.4
Cha, S.5
-
121
-
-
70849096115
-
Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation
-
Yan SF, Du Yan S, Ramasamy R, Schmidt AM. Tempering the wrath of RAGE: An emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med.2009;25:1-15.
-
(2009)
Ann Med
, vol.25
, pp. 1-15
-
-
Yan, S.F.1
du Yan, S.2
Ramasamy, R.3
Schmidt, A.M.4
-
122
-
-
0030811664
-
Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury
-
Soulis T, Thallas V, Youssef S, et al. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia. 1997;40:619-628.
-
(1997)
Diabetologia
, vol.40
, pp. 619-628
-
-
Soulis, T.1
Thallas, V.2
Youssef, S.3
-
123
-
-
31644450524
-
Upregulation of RAGE and its ligands in proliferative retinal disease
-
Pachydaki SI, Tari SR, Lee SE, et al. Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res. 2006;82:807-815.
-
(2006)
Exp Eye Res
, vol.82
, pp. 807-815
-
-
Pachydaki, S.I.1
Tari, S.R.2
Lee, S.E.3
-
124
-
-
4644344743
-
Receptor for advanced glycation end products and age-related macular degeneration
-
Howes KA, Liu Y, Dunaief JL, et al. Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Visual Sci. 2004;45:3713-3720.
-
(2004)
Invest Ophthalmol Visual Sci
, vol.45
, pp. 3713-3720
-
-
Howes, K.A.1
Liu, Y.2
Dunaief, J.L.3
-
126
-
-
77449142258
-
Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands
-
Yao D, Brownlee M. Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands. Diabetes. 2010;59: 249-255.
-
(2010)
Diabetes
, vol.59
, pp. 249-255
-
-
Yao, D.1
Brownlee, M.2
-
127
-
-
78649333713
-
Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia responses are regulated by the receptor for advanced glycation end-products (RAGE)
-
In press
-
Zong H, Ward M, Madden A, Yong PH, Limb GA, Stitt AW. Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia responses are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia. 2010. In press.
-
(2010)
Diabetologia
-
-
Zong, H.1
Ward, M.2
Madden, A.3
Yong, P.H.4
Limb, G.A.5
Stitt, A.W.6
-
128
-
-
4644342944
-
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products
-
Marx N, Walcher D, Ivanova N, et al. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. Diabetes. 2004;53:2662-2668.
-
(2004)
Diabetes
, vol.53
, pp. 2662-2668
-
-
Marx, N.1
Walcher, D.2
Ivanova, N.3
-
129
-
-
8444249207
-
Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation
-
Yamagishi S, Takeuchi M. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation. Drugs Exp Clin Res. 2004;30:169-175.
-
(2004)
Drugs Exp Clin Res
, vol.30
, pp. 169-175
-
-
Yamagishi, S.1
Takeuchi, M.2
-
130
-
-
23644432209
-
Angiotensin II augments advanced glycation end product- induced pericyte apoptosis through RAGE overexpression
-
Yamagishi S, Takeuchi M, Matsui T, Nakamura K, Imaizumi T, Inoue H. Angiotensin II augments advanced glycation end product- induced pericyte apoptosis through RAGE overexpression. FEBS Lett. 2005;579:4265-4270.
-
(2005)
FEBS Lett
, vol.579
, pp. 4265-4270
-
-
Yamagishi, S.1
Takeuchi, M.2
Matsui, T.3
Nakamura, K.4
Imaizumi, T.5
Inoue, H.6
-
131
-
-
27744574284
-
Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension
-
Nakamura K, Yamagishi S, Nakamura Y, et al. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvasc Res. 2005;70:137-141.
-
(2005)
Microvasc Res
, vol.70
, pp. 137-141
-
-
Nakamura, K.1
Yamagishi, S.2
Nakamura, Y.3
|